Invention Grant
- Patent Title: Treatment of autism spectrum disorder and associated symptoms
-
Application No.: US16872473Application Date: 2020-05-12
-
Publication No.: US11744891B2Publication Date: 2023-09-05
- Inventor: Richard Louis Price
- Applicant: Richard Louis Price
- Applicant Address: US NY Suffern
- Assignee: Richard Louis Price
- Current Assignee: Richard Louis Price
- Current Assignee Address: US NY Suffern
- Agency: Eckert Seamans Cherin & Mellott, LLC
- Agent David B. Gornish
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A23L3/3553 ; C07F9/117 ; A61K31/4168 ; A61K31/155 ; A61K31/165 ; A61K9/00 ; A61K31/047 ; A61K45/06 ; A61J1/00 ; A61K39/00

Abstract:
Disclosed is a single unit oral dosage form having, in combination, inositol and an extended release clonidine or extended release guanfacine. In one aspect, a method for treating ADHD and/or associated symptoms thereof includes administering to an ADHD patient the single unit oral dosage form. In another aspect, a method for treating ADHD and/or associated symptoms thereof includes administering to an ADHD patient inositol in combination with extended release clonidine or extended release guanfacine, whether administered separately or as a single dosage form.
Public/Granted literature
- US20200268882A1 TREATMENT OF AUTISM SPECTRUM DISORDER AND ASSOCIATED SYMPTOMS Public/Granted day:2020-08-27
Information query